Supernus Pharmaceuticals Inc $8.93
|Trade Time:||Mar 12 09:41 AM Eastern Daylight Time|
|Change:||0.04 (0.45 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get SUPN Trend Analysis - it has underperformed the S&P 500 by 4%
|No ETF alternatives available.|
|Date||Name||Title||Volume||Trade Price||Holding Change|
|8/19/2013||Bhatt Padmanabh P.||Sr. VP of IP; CSO||-2,285||$8.21||-4.22%|
|3/21/2013||SIEBERT JOHN M||Director||3,000||$5.50||24.61%|
|3/15/2013||Khattar Jack A.||President, CEO||10,000||$6.15||2.49%|
|3/14/2013||PATRICK GREGORY S||VP, Chief Financial Officer||5,000||$6.95||128.11%|
SUPN Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!